Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive
| Image |  |
|---|---|
| Description | scientific article published on 26 January 2018 |
| Author/s |
author: Zbigniew I Nowecki Seock-Ah Im Xavier Pivot Marek Wojtukiewicz |
| Publication date | January 26, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |